BGI Collaborations

Autism Speaks

Quote: “Autism Speaks enjoys a productive collaboration with BGI, a leader in the global genome sequencing arena which uses its scientific expertise and technological knowhow to improve medical research.

Our collaboration with BGI on the 10K Genome Project, a groundbreaking endeavor to analyze 10,000 human genomes, involves one of the largest genome collections ever studied for a single disorder. The goal of this collaboration is to discover the genetic markers and risk genes of autism and to aid the development of novel diagnostics and treatments. This collaboration will transform the field and accelerate basic and translational research in autism and related developmental disabilities.

We appreciate the research and scientific expertise that BGI brings to the collaboration, its contributions to the advancement of new diagnostics and treatments for autism disorders, including the inspirational speech Dr. Huanming Yang, co-founder of BGI, gave at the Autism Research Collaboration Development Meeting earlier this year.” - Andy Shih, Vice President of Scientific Affairs, Autism Speaks

Press Release: Autism Speaks and BGI Collaboration to Generate World’s Largest Library of Sequenced Genome of Individuals with Autism Spectrum Disorders (October 13, 2011)

Tackling the Whole Autism Genome: Insights for Diagnosis & Care (July 11, 2013)

Publication: Jiang, Y. et al. (2013). Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing. American Journal of Human Genetics. 93, 249-263.

 Bill & Melinda Gates Foundation

Press Release: BGI and the Bill & Melinda Gates Foundation Sign Memorandum of Understanding on Collaboration for Global Health and Agricultural Development (September 25, 2012)

 The Children’s Hospital of Philadelphia

Press Releases: CHOP and BGI Strengthen Partnership with Agreement on Pediatric Brain Tumor Collaboration in Support of the Childhood Brain Tumor Tissue Consortium (January 10, 2013)

BGI’s First International Conference on Genomics in the Americas Provides Updates on Applications of Latest Technologies to Advance Personalized Medicine and Increase Global Food Production (October 1, 2012)

[email protected] Joint Genome Center to Offer Clinical Next-Generation Sequencing Services (September 27, 2012)

BGI and The Children’s Hospital of Philadelphia Launch The 1,000 Rare Diseases Project to Advance Gene Discovery (June 18, 2012)

The Children’s Hospital of Philadelphia and BGI Announce Partnership and New Joint Genome Center to Target Pediatric Diseases (November 9, 2011)

More Collaborations

2014-09-12: BGI and The Vancouver Prostate Centre Announce Partnership to Create Joint Research Laboratory for Advancement of Translational Cancer Research

BGI, the world’s largest genomics organization, based in China, and The Vancouver Prostate Centre (VPC), a global leader in translational research in cancer, announced the establishment of the BGI-VPC Joint Research Laboratory, a sequencing and translational research facility, to jointly discover and advance basic and translational programs in oncology, including personalized oncology. The collaboration, the first between BGI and any Canadian research institution, will change the landscape of genomic and translational research across Canadaand benefit patients worldwide.

2014-07-29: QIAGEN Agrees with BGI Tech to Provide Services Based on the Human Gene Mutation Database (HGMD) in Greater China

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and BGI Tech Solutions Co., Ltd. (BGI Tech), a subsidiary of BGI, the world’s largest genomics organization, announced that they have entered into a distribution and service agreement for the Human Gene Mutation Database (HGMD®) in Greater China. Under the agreement, BGI Tech will serve the Chinese market including providing first level support for the database.

2014-07-07: BGI Announces World-Leading Research Centre with the University of Birmingham

BGI, the world’s largest genomics research institute, has signed a ground breaking agreement with the University of Birmingham that will create the Joint Centre for Environmental Omics (JCEO) between the two institutions. The JCEO will seek to protect environment, health and global biodiversity by analysing the toxicity of compounds more efficiently than has been achieved before.

2014-05-07: Unilabs and BGI Sign Innovative Collaboration Agreement

Unilabs, a leading medical diagnostic services company in Europe and BGI, one of the world’s largest genomics research centres, have signed a collaboration agreement. This partnership will strengthen Unilabs’ position as a leader in genetic testing, complementing the very broad range of genetics services offered throughout an integrated lab network. Unilabs is committed to bringing innovative tests and solutions to customers in Europe.

2013-11-15: BGI Tech and Carlsberg Laboratory Joined Collaboration for the DNA Sequencing of Barley Chromosome 6

Carlsberg Laboratory, created in 1875, and BGI Tech Solutions Co., LTD, (BGI Tech), a subsidiary of BGI, the world’s largest genomics research organization, jointly announce their partnership to decode the DNA sequence of barley chromosome 6 with the aim to provide a valuable resource for the development of new barley cultivars.

2013-10-21: BGI Partners With Life Technologies to Offer Faster, More Affordable Sequencing Applications on Ion Torrent™

Life Technologies Corporation (NASDAQ: LIFE) and BGI, the world’s largest genomics center and service provider, jointly announced that BGI has purchased 38 Ion Proton™ Sequencers and plans to add at least a dozen more by the end of the year, strengthening the organization’s leadership position in the genomics industry. BGI also signed a supply and licensing agreement with Life Technologies, further enhancing BGI’s ability to perform basic, agricultural and clinical research.

2013-09-30: Coimbra Genomics and BGI Join Forces to Conquer Stomach Cancer

China’s genomics powerhouse BGI and Portugal-based start-up Coimbra Genomics today announced the initiation of a joint project to unravel the genetic basis of gastric cancer. With an initial budget of over $900k, the project will be one of the first large-scale genomic studies this field, and will involve experts from the IPATIMUP, a leading cancer research institute based in Oporto, Portugal, with a particularly strong track-record on gastric cancer.

2013-09-12: BGI Tech and South Texas Accelerated Research Therapeutics Initiate Collaboration to Advance Unique San Antonio 1000 Cancer Genome Project

BGI Tech Solutions Co., LTD, (BGI Tech), a subsidiary of BGI, the world’s largest genomics research organization, and South Texas Accelerated Research Therapeutics (START), announced today that they are collaborating on the San Antonio 1000 Cancer Genome Project, a groundbreaking cancer genome study designed to link genetic alterations that underlie different cancers to detailed clinical outcomes.

2013-06-17: BGI Forms New Partnership with Three Universities in Turkey for Advancing Genomics and its Clinical Applications

BGI today announces it has formed new partnership with Bogazici Univeristy, Acibadem University, and Cankiri Karatekin University, respectively. Mr. Qin Xu, Mayor of Shenzhen, China and Kadir Topbaş, Mayor of Istanbul together witnessed these strategic collaborations at a Sino-Turkey signing ceremony attended by numerous Chinese and Turkish universities, institutes and enterprises.

2013-04-19: Collaboration to Establish New Computational Resources for Metabolomics

A partnership between the University of Birmingham, BGI and its open-access journal, GigaScience, has received funding from the UK’s Natural Environment Research Council (NERC) to develop a software platform for the analysis of large-scale environmental metabolomics data.

2013-03-21: H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data

H3 Biomedicine Inc., a biopharmaceutical company specializing in the discovery and development of oncology treatments, and BGI, the largest genomics organization in the world, jointly announced today that they have entered into a partnership to sequence and publish genomic data from pre-clinical cancer models. This research, which aims to identify and validate recurrent gene mutations that are potential targets for drug therapies, is crucial for the entire oncology drug discovery industry.

2013-03-08: BGI Europe Collaborates with GENNET on Genetic Screening for Mendelian Disorders

BGI Europe, one of BGI’s affiliates, and GENNET, a center for genetics, fetal medicine and assisted reproduction, signed a Memorandum of Understanding (MOU) on genetic screening for Mendelian disorders. This partnership aims to encourage collaborative initiatives in the area of monogenic disease.

2013-01-16: China National Genebank and Smithsonian’s National Museum of Natural History Collaborate on Biobanking to Advance Biodiversity Research

China National Genebank (Shenzhen), also referred to as “CNGB-Shenzhen”, and National Museum of Natural History (NMNH), U.S.A. jointly announced that they have reached a strategic agreement to promote biorepository and genomics research, as well as to enhance the mutual exchanges of experience in resource collection and sharing, infrastructure construction and information management.

2012-10-29: British Library leads the way for sharing research data in the UK as five major institutions sign up to DataCite

Five major data centres have expanded their commitment to make research data more accessible through the British Library’s DataCite service, a global initiative that addresses the problem of how to find, access and re-use the results of research. BGI is the first Asian data centre, alongside the UK based Archaeology Data Service, the UK Data Archive, the Natural Environment Research Council, the Science & Technology Facilities Council that have signed up to the service and are the first institutions to work with the British Library on this initiative.

2012-10-16: BGI Forms Partnership with GENNET for Non-invasive Fetal Trisomy Test- Aiming to significantly improve reproductive health in Czech and Slovak Republics

BGI and GENNET, a center for genetics, fetal medicine and assisted reproduction, jointly announced that they have entered a collaborative agreement on non-invasive fetal trisomy (NIFTY) test with the aim to significantly improve reproductive health in Czech and Slovak Republics.

2012-09-25: BGI and INEX Enter Collaborative Agreement for Significantly Improving Reproductive Health

BGI announced that it and INEX Innovations Exchange Pte Ltd (INEX), a leading women’s health diagnostics company based in Singapore, have formed a partnership to establish a Next Generation Sequencing (NGS) facility in Singapore to offer a suite of molecular genetics tests, starting with a non-invasive fetal trisomy (NIFTY) test to detect fetal chromosomal abnormalities in pregnant women.

2012-09-24: BGI Enters Collaborative Agreement with Griffith University Boosting Education and Scientific Research

BGI and Griffith University, one of the most influential universities in the Asia-Pacific region, jointly announced that they came into a mutual agreement to conduct collaborations in teaching, training, research and other activities.

2012-08-01: BGI partners with the University of Birmingham

The University of Birmingham and BGI have announced a major joint initiative in environmental and human health research. The new venture will provide a world-class research and training centre on Birmingham’s campus that integrates state-of-the-art approaches in molecular biology, including DNA sequencing, metabolomics and bioinformatics. Research will focus on organism responses to environmental change through to disease susceptibility and treatment.

2012-07-24: University of Edinburgh link-up with BGI to boost genetic research

Research in the growing field of genomics –which could lead to a new generation of personalised medical treatments – will be boosted by an initiative that brings together scientific expertise from China and Edinburgh. A memorandum of understanding signed between the University of Edinburgh and BGI, the world’s largest genomics organisation, will aim to build on both institutions’ strengths in genomics.

2012-06-12: BGI, GE Healthcare team up on pioneering stem cell science projects

GE Healthcare, the healthcare business of GE (NYSE: GE), and BGI jointly announced a pioneering multi-year research collaboration in stem cell science. The objective of the collaboration is to help advance the potential global utility of stem cell-derived assays for use in drug discovery and toxicity testing by exploring the underlying genetic variation between ethnically diverse human stem cell lines.

2012-05-02: BGI, George Mason University, the Massachusetts Eye and Ear Infirmary and the University of Oklahoma Health Sciences Center Announce Agreement to Sequence 100 Human Adenoviruses

Representatives from BGI in conjunction with George Mason University (GMU), the Massachusetts Eye and Ear Infirmary (Mass. Eye and Ear) and the University of Oklahoma Health Sciences Center (OUHSC), jointly announce that they have signed an agreement to sequence 100 human adenoviruses gathered from researchers globally, including ones that cause respiratory, gastrointestinal and ocular diseases.

2012-04-25: BGI and Aspera Collaborate on High-speed Data Exchange to Advance Genome Research

Aspera, Inc., creators of next-generation software technologies that move the world’s data at maximum speed, and BGI, the world’s largest genomics research institute, announced at Bio-IT World that they have partnered to integrate and deploy the Aspera Connect Server and Aspera fasp™ high-speed file transferring technology with “EasyGenomics™”,BGI’s latest cloud-based Software as a Service (SaaS) platform, and to expand BGI’s high speed sequencing data delivery service.

2012-04-24: ICRISAT and BGI seals research partnership on modern sequencing technologies for molecular crop breeding

BGI and the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT) jointly announced the signing of a Memorandum of Understanding (MoU) for a long-term collaboration on applied genomics research and molecular breeding. The partnership primarily aims to enhance precision of breeding programs for semi-arid tropic crops by using next-generation sequencing technologies towards crop improvement for sustainable food production particularly in the drylands of Asia and sub-Saharan Africa.

2012-03-23: BGI Signs MOU with TTI GG, NLeSC and NBIC for Taming Flood of Genomic Data

BGI, Technological Top Institute of Green Genetics (TTI GG), Netherlands eScience Centre (NLeSC), and Netherlands Institute of Bioinformatics (NBIC) signed a Memorandum of Understanding (MOU) to address the challenge of managing, transporting, integrating and analysing today’s tremendous flow of genomic data. The collaborating organisations advocate the adoption and application of Open Source and Open Access initiatives to genomic data to more easily and rapidly explore the mysteries of life science.

2012-03-21: BGI, University of Helsinki and Wuhan University Enter into a MOU Concerning Cooperation on Genomics Research

To facilitate the genomics research and communication between BGI, University of Helsinki and Wuhan University, researchers from these organizations have reached a Memorandum of Understanding (MOU) setting forth a framework for some subjects of mutual interest in the field of genomics, such as archaeal organisms from hypersaline environments, among others.

2012-03-03: BGI Enters Collaborative Agreement with Lal Teer Livestock Limited Targeting Water Buffalo Genome Project

Lal Teer Livestock Limited, an associate of Lal Teer Seed Ltd., the largest seed company in Bangladesh with strong hybrid research program, and BGI jointly announced that they came to a mutual agreement to conduct collaborative water buffalo genome sequencing and bioinformatics analysis.

2012-03-02: Novo Nordisk and BGI Establish Global Collaboration Framework

Novo Nordisk, one of the world’s leading companies in diabetes care and BGI jointly announced that they have reached an agreement to establish a global collaboration framework, which provides an unprecedented collaborative opportunity for Novo Nordisk and BGI to accelerate their growth, execute their global partnering strategy and support disease research and development efforts.

2012-02-29: Agilent Technologies and BGI to Collaborate on Next-Generation Super Array for Disease and Drug Research

Agilent Technologies Inc. (NYSE: A) and BGI announced a collaborative effort to develop methodologies designated for next-generation genome-wide association studies. The methodologies will assist scientists pursuing disease and drug research.

2012-02-17: BGI and Asia Cancer Research Group (ACRG) Announce Collaboration to Accelerate Cancer Research in Asia

BGI and Asia Cancer Research Group (ACRG) jointly announced a new collaboration on cancer genomics research as part of ACRG’s mission to generate a unique and best-in-class data source on cancers prevalent in Asia, and to accelerate research and development of improved treatments for those cancers by freely sharing the resulting data with the scientific community

2012-01-14: Affymetrix and BGI Enter Strategic Collaboration to Co-Develop and Commercialize Genomic Microarrays for the Agricultural Community

Affymetrix®, Inc. (NASDAQ:AFFX), announced that it has signed a Memorandum of Understanding (MOU) with BGI to enter into a strategic co-development and co-marketing collaboration. The non-exclusive partnership will aim to develop and commercialize a portfolio of plant, crop and livestock microarrays for genotyping analysis, spanning applications such as marker assisted trait selection, parentage, quality control and traceability.

2012-01-10: RainDance Technologies Teams with Hospital Saint-Louis and BGI to Confirm Mutations Associated with Rheumatoid Arthritis

RainDance Technologies, Inc., the Digital Biology™ Company, announced that it was collaborating with the Hôpital Saint-Louis in Paris, France and BGI in China, the world’s largest genomics institute, to discover new variants and confirm findings from a Rheumatoid Arthritis (RA) study conducted by researchers at the Hôpital Saint-Louis.